Victoza and Exostosis - a phase IV clinical study of FDA data

Summary:

Exostosis is reported as a side effect among people who take Victoza (liraglutide), especially for people who are female, 60+ old, also take Metformin, and have High blood pressure.

The phase IV clinical study analyzes which people have Exostosis when taking Victoza. It is created by eHealthMe based on reports of 42,028 people who have side effects when taking Victoza from the FDA, and is updated regularly.

What is Victoza?

Victoza has active ingredients of liraglutide. It is often used in diabetes. eHealthMe is studying from 42,880 Victoza users. Check the latest studies of Victoza.

What is Exostosis?

Exostosis (formation of new bone on the surface of a bone) is found to be associated with 1,091 drugs and 928 conditions by eHealthMe. Check the latest studies of Exostosis.

On Jul, 10, 2026

42,028 people reported to have side effects when taking Victoza.
Among them, 16 people (0.04%) have Exostosis.

Among these 16 people:

What is the gender of people who have Exostosis when taking Victoza? *

female: 68.75 %
male: 31.25 %

What is the age of people who have Exostosis when taking Victoza? *

What are other drugs people take besides Victoza? *

What are other side effects people have besides Exostosis? *

Drug Ineffective: 6 people, 37.50%
Weight Decreased: 5 people, 31.25%
Weight Increased: 4 people, 25.00%
Nausea (feeling of having an urge to vomit): 4 people, 25.00%
Blood Glucose Increased: 4 people, 25.00%
Tendon Injury: 3 people, 18.75%
Joint Range Of Motion Decreased (disease of joint movement): 3 people, 18.75%
Joint Pain: 3 people, 18.75%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 18.75%
Hypophagia (reduced food intake): 3 people, 18.75%

What are the existing conditions these people have? *

High Blood Pressure: 6 people, 37.50%
Pain: 5 people, 31.25%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 4 people, 25.00%
Breakthrough Pain: 3 people, 18.75%
Heart Attack: 3 people, 18.75%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 2 people, 12.50%
Blood Oestrogen Decreased: 2 people, 12.50%
Constipation: 2 people, 12.50%
Weight Decreased: 1 person, 6.25%
Erection Problems: 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Victoza and have Exostosis?

- Check whether Exostosis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Victoza:

Victoza (42,880 reports)

Exostosis treatments and more:

Exostosis (13,639 reports)

Browse all side effects of Victoza:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Exostosis:

Exostosis (1,091 drugs)

Browse all the conditions that are associated with Exostosis:

Exostosis (928 conditions)

Related publications that referenced our studies

Fontoura P, de Almeida Cardoso MC, Erthal-Martins MC, Werneck C, Sartorio C, Ramos CF, "The effects of liraglutide on male fertility: a case report", Reproductive biomedicine online, 2014 Nov .
Fontoura P, de Almeida Cardoso MC, Erthal-Martins MC, Werneck C, Sartorio C, Ramos CF, "The effects of liraglutide on male fertility: a case report", Reproductive biomedicine online, 2014 Nov .

How the study uses the data?

The study uses data from the FDA. It is based on liraglutide (the active ingredients of Victoza) and Victoza (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.